Clinical Trial Update: Safety and Efficacy of Intranasal Epinephrine After Administration of ARS -1 in Subjects With Frequent Urticaria Flares [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of ARS-1 with intranasal epinephrine in subjects with frequent urticaria flares has completed and posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urticaria

Drugs mentioned

• ARS-1
• intranasal epinephrine (epinephrine)

Snippet

Sponsor: ARS Pharmaceuticals, Inc. | Conditions: Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2026-04-07